Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$4.05 USD
-1.96 (-32.61%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $4.04 -0.01 (-0.25%) 7:48 PM ET
5-Strong Sell of 5 5
C Value B Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 941 - 960 ( 1026 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
LINZESS Weekly Retail Sales Tracker - Week Ending June 21
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
LINZESS Weekly Retail Sales Tracker - Week ending June 14
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
LINZESS Weekly Retail Sales Tracker - Week Ending May 24
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New Drug Launch Weekly Retail Sales Tracker - Week Ending 24
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Upgrading to NEUTRAL from UNDERPERFORM; Adjusting Estimates for the Recently Completed Financing and Linzess Script Metrics
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Raising Another $150M-Plus in Equity, Another $200M Needed to Bridge to Profitability, in Our View, Reiterate UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
LINZESS Weekly Retail Sales Tracker - Week Ending May 10
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week Ending May 10
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
New Drug Launch Weekly Retail Sales Tracker - Week Ending May 3
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense - New Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C